-
公开(公告)号：US11246990B2
公开(公告)日：2022-02-15
申请号：US15906946
申请日：2018-02-27
Applicant: DexCom, Inc.
Inventor： James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv Ullas Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
IPC: A61M31/00 , A61M1/00 , A61M5/315 , A61B5/1486 , A61M15/00 , A61M11/00 , A61B5/00 , A61B5/145 , A61M5/172 , G16H40/63 , G16H10/40 , G16H20/17
Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
-
372.发明授权公开(公告)号：US11222724B2
公开(公告)日：2022-01-11
申请号：US15699989
申请日：2017-09-08
Applicant: DexCom, Inc.
Inventor： Anna Leigh Davis , Scott M. Belliveau , Esteban Cabrera, Jr. , Alexandra Elena Constantin , Rian Draeger , Peter Galuardi , Hari Hampapuram , Matthew Lawrence Johnson , Apurv Ullas Kamath , Katherine Yerre Koehler , Aarthi Mahalingam , Gary A. Morris , Philip Thomas Pupa , Peter C. Simpson , Brian Christopher Smith , Tomas C. Walker
IPC: G16H40/63 , G16H80/00 , G16H10/60 , G16H50/30 , A61M5/172 , G06F21/44 , G16H40/67 , G16H20/17 , G16H10/20 , G06F21/60 , G06F21/62 , A61M5/142 , G16H20/30 , G16H20/70 , G16H20/60
Abstract: Disclosed are systems and methods for secure and seamless set up and modification of bolus calculator parameters for a bolus calculator tool by a health care provider (HCP). In one aspect, a method for enabling HCP set up of a bolus calculator includes providing a server accessible by both an HCP and a patient; upon login by the HCP, displaying, or transmitting for display, a fillable form, the fillable form including one or more fields for entry of one or more bolus calculator parameters; receiving data from the fillable form, the data corresponding to one or more bolus calculator parameters; and upon login by the patient, transmitting data to a device associated with the patient, the transmitted data based on the received data, where the transmitted data corresponds to one or more of the bolus calculator parameters in a format suitable for entry to a bolus calculator.
-
公开(公告)号：US11153317B2
公开(公告)日：2021-10-19
申请号：US16169661
申请日：2018-10-24
Applicant: DexCom, Inc.
Inventor： Apurv Ullas Kamath , Michael Robert Mensinger , Nicholas Polytaridis , Gary A. Morris , Alexandra E. Constantin , Douglas William Burnette , Mario Remon , Jorge R. Barreras , Benjamin Elrod West , Christopher R. Hannemann
IPC: H04L9/32 , H04L29/06 , H04W52/02 , A61B5/145 , H04W12/06 , A61B5/00 , G16H10/60 , G16H50/20 , G16H10/65 , H04W76/14 , H04W4/38 , H04W4/80 , A61B5/1495
Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.
-
公开(公告)号：US20210267506A1
公开(公告)日：2021-09-02
申请号：US17188675
申请日：2021-03-01
Applicant: DexCom, Inc.
Inventor： Mark Edward Selander , Alexander Michael Diener , Ryan Richard Ruehl , Kazanna Calais Hames , Mark Douglas Kempkey , Chad Michael Patterson , Apurv Ullas Kamath , Matthew Lawrence Johnson , Jason M. Halac , David A. Price , Peter C. Simpson , Devon M. Headen , Samuel Isaac Epstein
Abstract: Techniques for data analysis and user guidance are provided. One or more current measurements of one or more current analyte levels for the user are received from a sensor. A pattern is generated based on the one or more current measurements and the one or more past measurements. A first alignment with a first user target is then determined based on the pattern, where the first user target relates to one or more of a mental state or physical state of the user. A first result is output to the user, based on the determined first alignment.
-
公开(公告)号：US20210260289A1
公开(公告)日：2021-08-26
申请号：US17114213
申请日：2020-12-07
Applicant: DexCom, Inc.
Inventor： Apurv Ullas Kamath , Derek James Escobar , Sumitaka Mikami , Hari Hampapuram , Benjamin Elrod West , Nathanael Paul , Naresh C. Bhavaraju , Michael Robert Mensinger , Gary A. Morris , Andrew Attila Pal , Eli Reihman , Scott M. Belliveau , Katherine Yerre Koehler , Nicholas Polytaridis , Rian Draeger , Jorge Valdes , David Price , Peter C. Simpson , Edward Sweeney
Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
-
Patent Agency Ranking
公开(公告)号：US20210260286A1
公开(公告)日：2021-08-26
申请号：US17114137
申请日：2020-12-07
Applicant: DexCom, Inc.
Inventor： Apurv Ullas Kamath , Derek James Escobar , Sumitaka Mikami , Hari Hampapuram , Benjamin Elrod West , Nathanael Paul , Naresh C. Bhavaraju , Michael Robert Mensinger , Gary A. Morris , Andrew Attila Pal , Eli Reihman , Scott M. Belliveau , Katherine Yerre Koehler , Nicholas Polytaridis , Rian Draeger , Jorge Valdes , David Price , Peter C. Simpson , Edward Sweeney
Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.
-
公开(公告)号：US20210259587A1
公开(公告)日：2021-08-26
申请号：US17316228
申请日：2021-05-10
Applicant: DexCom, Inc.
Inventor： Peter C. Simpson , Ying Li , Apurv Ullas Kamath , Richard C. Yang
IPC: A61B5/1495 , A61B5/145
Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
-
公开(公告)号：US11102306B2
公开(公告)日：2021-08-24
申请号：US16937440
申请日：2020-07-23
Applicant: DexCom, Inc.
Inventor： Michael Robert Mensinger , John Michael Dobbles , Apurv Ullas Kamath , Beat Stadelmann , Deborah M. Ruppert , Nasser Salamati , Richard C. Yang
Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.
-
公开(公告)号：US20210251526A1
公开(公告)日：2021-08-19
申请号：US17207461
申请日：2021-03-19
Applicant: DexCom, Inc.
Inventor： Michael J. Estes , Stephen J. Vanslyke , Apurv Ullas Kamath , Thomas A. Peyser , Lucas Bohnett , Aarthi Mahalingam , Arturo Garcia , Peter C. Simpson , Anna Leigh Davis , Sebastian Böhm
IPC: A61B5/1495 , A61B5/145 , G01D3/02 , A61B5/00
Abstract: Systems and methods for applying time-dependent algorithmic compensation functions to data output from a continuous analyte sensor. Some embodiments determine a time since sensor implantation and/or whether a newly initialized sensor has been used previously.
-
公开(公告)号：US11064917B2
公开(公告)日：2021-07-20
申请号：US17161103
申请日：2021-01-28
Applicant: DexCom, Inc.
Inventor： Peter C. Simpson , James H. Brauker , Mark C. Brister , Paul V. Goode, Jr. , Apurv Ullas Kamath , Aarthi Mahalingam , Jack Pryor , Matthew D. Wightlin
IPC: A61B5/1468 , A61B5/1486 , A61B5/1473 , A61B5/1495 , A61B5/145 , A61B5/05 , A61B5/00 , A61B17/34 , A61B5/15 , A61M5/158 , A61M5/172 , A61M5/142
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
-
-
-
-
-
-
-
-
-
Search Results
442
records
(took 0.03 seconds)
